Kepler Capital Sticks to Its Buy Rating for Valneva (0OB3)
In a report released on February 5, Justine Telliez from Kepler Capital maintained a Buy rating on Valneva (0OB3 – Research Report), with a ...
Neurological conditions that mimic Guillain-Barré Syndrome and how to differentiate them
GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...
Valneva stock holds $18 target on UK vaccine nod
H.C. Wainwright reaffirmed its Buy rating and $18.00 price target for Valneva (EPA:VLS) SE (NASDAQ:VALN) shares, following the recent approval of the company's Ixchiq vaccine in the United Kingdom ...
PMLiVE16h
MHRA approves Valneva’s chikungunya vaccine Ixchiq for use in adults
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use ...
US bird flu outbreak in cattle: The global risk to humans
A second type of the virus, D1.1, has been detected in dairy cattle in Nevada, US. A second type of bird flu H5N1 detected in ...
Horror concerns erupt over 'antimicrobial resistance' linked to flies in hospital wards
Flies circulating in hospital wards may pose a threat to vulnerable patients by spreading bacteria that are resistant to ...
Pharmabiz22h
UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq
UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq: Saint Herblain, France Thursday, February 6, 2025, 12:00 Hrs [IST] Valneva SE, a specialty vacci ...